山東威達(002026.SZ):2019年度擬計提減值準備3.01億元
格隆匯2月25日丨山東威達(002026.SZ)公佈,公司於2020年2月25日召開第八屆董事會第七次臨時會議,審議通過了《關於2019年度計提資產減值準備的議案》。經過公司及下屬子公司對截至2019年12月31日可能發生減值跡象的資產進行資產減值測試後,擬計提減值準備金額合計3.01億元。
此次計提資產減值準備使公司2019年度合併報表歸母淨利潤減少2.99億元,歸屬於母公司所有者權益減少2.99億元,公司此次計提的資產減值準備未經會計師事務所審計,最終以會計師事務所審計的財務數據為準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.